The group’s principle activity is to develop next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of abdominal aortic aneurysms. The group’s products include Aptpus(TM)endograft and Aptus(TM)endovascular AAA repair system. The group operates from United States.